Related Experiment Video
Updated: May 18, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
Published on: May 2, 2018
The sequence-activity relationship between metallo-β-lactamases IMP-1, IMP-6, and IMP-25 suggests an evolutionary
Eleanor M Liu1, Kevin M Pegg, Peter Oelschlaeger
1Department of Pharmaceutical Sciences, Western University of Health Sciences, Pomona, CA, USA.
Abstract:
Metallo-β-lactamases are important determinants of antibacterial resistance. In this study, we investigate the sequence-activity relationship between the closely related enzymes IMP-1, IMP-6, and IMP-25. While IMP-1 is the more efficient enzyme across the overall spectrum of tested β-lactam antibacterial agents, IMP-6 and IMP-25 seem to have evolved to specifically inactivate the newer carbapenem meropenem. Molecular modeling indicates that the G235S mutation distinguishing IMP-25 from IMP-1 and IMP-6 may affect enzyme activity via Asn233.
Insights
Metallo-β-lactamases (MBLs) confer antibacterial resistance. IMP-1 is broadly active, while IMP-6 and IMP-25 specifically target meropenem, potentially due to a G235S mutation influencing enzyme activity.
Area of Science:
- Microbiology
- Biochemistry
- Structural Biology
Background:
- Metallo-β-lactamases (MBLs) are critical enzymes mediating bacterial resistance to β-lactam antibiotics.
- Understanding the structure-activity relationships of MBLs is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the sequence-activity relationship among closely related MBLs: IMP-1, IMP-6, and IMP-25.
- To elucidate the molecular basis for differential substrate specificities, particularly concerning carbapenem inactivation.
Main Methods:
- Enzyme activity assays across a spectrum of β-lactam antibiotics.
- Molecular modeling to analyze structural differences and their potential impact on enzyme function.
Main Results:
- IMP-1 exhibits broader activity against various β-lactam agents.
- IMP-6 and IMP-25 demonstrate enhanced specificity for inactivating the carbapenem meropenem.
- Molecular modeling suggests the G235S mutation in IMP-25 influences activity, potentially through interactions with Asn233.
Conclusions:
- IMP-1, IMP-6, and IMP-25 display distinct substrate profiles, highlighting evolutionary divergence in MBLs.
- The G235S mutation is a key factor in the carbapenem-specific activity of IMP-25.
- These findings provide insights into MBL resistance mechanisms and potential targets for antimicrobial drug development.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Transduction
Development of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
